TEACHER RETIREMENT SYSTEM OF TEXAS - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 91 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
TEACHER RETIREMENT SYSTEM OF TEXAS ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$380
+5.6%
53,640
+4.9%
0.00%
+50.0%
Q2 2023$360
-24.8%
51,121
-11.0%
0.00%
-33.3%
Q1 2023$479
-25.6%
57,430
+2.4%
0.00%
-40.0%
Q4 2022$644
-99.9%
56,078
-8.1%
0.01%
-16.7%
Q3 2022$769,000
+153.0%
61,051
+112.4%
0.01%
+200.0%
Q2 2022$304,000
-48.6%
28,741
-20.9%
0.00%
-33.3%
Q1 2022$591,000
+24.9%
36,342
+6.4%
0.00%
+50.0%
Q4 2021$473,000
+19.1%
34,141
+23.6%
0.00%0.0%
Q3 2021$397,000
+9.7%
27,631
+20.5%
0.00%0.0%
Q2 2021$362,000
+82.8%
22,923
+17.8%
0.00%
+100.0%
Q1 2021$198,000
+67.8%
19,465
+23.1%
0.00%0.0%
Q4 2020$118,000
+45.7%
15,813
+12.5%
0.00%0.0%
Q2 2018$81,000
-22.1%
14,060
-35.4%
0.00%0.0%
Q1 2018$104,000
-32.9%
21,773
-31.1%
0.00%0.0%
Q4 2017$155,000
+573.9%
31,595
+284.2%
0.00%
Q2 2016$23,000
+4.5%
8,224
+8.1%
0.00%
Q1 2016$22,000
-60.0%
7,609
+42.5%
0.00%
Q4 2015$55,000
-32.1%
5,341
-24.8%
0.00%
-100.0%
Q3 2015$81,000
+145.5%
7,106
+217.5%
0.00%
Q2 2015$33,000
+106.2%
2,238
+28.5%
0.00%
Q1 2015$16,000
-23.8%
1,742
+0.2%
0.00%
Q4 2014$21,000
+5.0%
1,739
-14.0%
0.00%
Q3 2014$20,000
-4.8%
2,022
+22.0%
0.00%
Q2 2014$21,000
+16.7%
1,6570.0%0.00%
Q1 2014$18,000
+50.0%
1,657
+1.5%
0.00%
Q4 2013$12,0001,6330.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$38,430,00018.43%
RTW INVESTMENTS, LP 4,078,895$25,819,0009.72%
VHCP Management, LLC 1,155,104$7,312,0007.86%
RA Capital Management 2,989,795$18,925,0002.68%
DLD Asset Management, LP 1,258,700$7,967,0002.61%
Avoro Capital Advisors LLC 1,631,502$10,327,0002.09%
Ghost Tree Capital, LLC 1,150,000$7,280,0001.75%
GREAT POINT PARTNERS LLC 725,000$4,589,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,237,734$20,495,0000.84%
Baker Brothers Advisors 10,963,944$69,402,0000.68%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders